Thi Thu Thuy Nguyen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thi Thu Thuy Nguyen has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Benno Kreuels
Research Group Neglected Diseases and Envenoming, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
1 shared publication - Jade Dean Rae
Research Group Neglected Diseases and Envenoming, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
1 shared publication - Joerg Blessmann
Research Group Neglected Diseases and Envenoming, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
1 shared publication - Jürgen May
Department of Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
1 shared publication - Nhan Phuc Thanh Nguyen
Institute for Community Health Research, University of Medicine and Pharmacy, Hue University, Hue 530000, Vietnam
1 shared publication - Ralf Krumkamp
Department of Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
1 shared publication
Latest Publications
- Open Access
- 26 June 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04225
The disease that bites – an assessment of demographics, clinical characteristics, and treatment practices of patients with snakebite envenoming across Vietnam
Snakebite envenoming presents a significant burden to the health care system in Vietnam. However, data on snakebite-related hospital visits and the availability of antivenom across the country remain scarce. Furthermore, details on clinical presentation, responsible snakes, and treatment practices are lacking. In this retrospective, cross-sectional study, we collected data on snakebite-related visits and antivenom availability in major hospitals across 40 provinces from 2018 to 2022 and analysed a subset of patients' files. We displayed the geographical distribution of snakebite-related visits, available antivenoms, and responsible snake species across Vietnam, described the clinical presentations of envenoming, and assessed the appropriateness of treatment practices. We recorded 23 877 snakebite-related visits from 2018 to 2022. Antivenom was available in 29 of 62 (46.8%) hospitals, more commonly in the southern provinces. In 2024 patient files, signs of haemotoxic envenoming and neurotoxic envenoming were recorded in 445 (22.0%) and 59 (2.9%) patients, respectively. The most frequently recorded snake genera were Trimeresurus and Naja. Antivenom was administered to 434 (33.9%) of the 1280 patients from antivenom-equipped hospitals. Ancillary treatments were commonly used: 1076 (53.1%) patients received antibiotics, and 940 (46.4%) received corticosteroids. In-hospital mortality was low at 0.3% and was mainly due to neurotoxic envenoming. We recorded a considerable number of snakebite-related visits in participating hospitals; however, antivenom availability was limited, and treatment practices were often inappropriate. Improving access to antivenom and updating national guidelines are essential to further reduce morbidity and mortality of snakebite in Vietnam.
- 26 June 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04225
Open AccessThe disease that bites – an assessment of demographics, clinical characteristics, and treatment practices of patients with snakebite envenoming across Vietnam
Snakebite envenoming presents a significant burden to the health care system in Vietnam. However, data on snakebite-related hospital visits and the availability of antivenom across the country remain scarce. Furthermore, details on clinical presentation, responsible snakes, and treatment practices are lacking. In this retrospective, cross-sectional study, we collected data on snakebite-related visits and antivenom availability in major hospitals across 40 provinces from 2018 to 2022 and analysed a subset of patients' files. We displayed the geographical distribution of snakebite-related visits, available antivenoms, and responsible snake species across Vietnam, described the clinical presentations of envenoming, and assessed the appropriateness of treatment practices. We recorded 23 877 snakebite-related visits from 2018 to 2022. Antivenom was available in 29 of 62 (46.8%) hospitals, more commonly in the southern provinces. In 2024 patient files, signs of haemotoxic envenoming and neurotoxic envenoming were recorded in 445 (22.0%) and 59 (2.9%) patients, respectively. The most frequently recorded snake genera were Trimeresurus and Naja. Antivenom was administered to 434 (33.9%) of the 1280 patients from antivenom-equipped hospitals. Ancillary treatments were commonly used: 1076 (53.1%) patients received antibiotics, and 940 (46.4%) received corticosteroids. In-hospital mortality was low at 0.3% and was mainly due to neurotoxic envenoming. We recorded a considerable number of snakebite-related visits in participating hospitals; however, antivenom availability was limited, and treatment practices were often inappropriate. Improving access to antivenom and updating national guidelines are essential to further reduce morbidity and mortality of snakebite in Vietnam.